GL1X · GenesisL1 explorer

MolNFT v1 · #82586 · protein

Crystal structure of the tyrosine kinase binding domain of cbl-C in complex with phospho-src peptide

3VRO · Signal transduction protein cbl-C: “Crystal structure of the tyrosine kinase binding domain of cbl-C in complex with phospho-src peptide”. X-ray diffraction, 1 ligand (CA), 3 pockets (best druggability 0.63). MolNFT v1 #82586 on…

PDB
3VRO
Type
protein
Length
289 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Signal transduction protein cbl-C; Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
Q9ULV8, P12931
Ligands
CA
Pockets
3 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 55% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASignal transduction protein cbl-Cprotein28456% helix, 9% strandQ9ULV8
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein50% helix, 0% strandP12931

Ligands and binding sites

  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.630.9025empty
21380.450.7718empty
3620.270.7316empty

Interfaces

1 interface between chains.

  • A–B · 386 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 3VRO · Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9ULV8 · AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase cbl-C (Q9ULV8) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.